Infigratinib靶向的FGFR3（成纤维细胞生长因子受体3）正是驱动ACH疾病发生的关键靶点，2月12日，BridgeBio公布Infigratinib在ACH中取得的首个具有统计学显著改善意义的3期顶线结果，公司计划下半年向FDA提交新药申请。
By pushing side effects to the edges and keeping our core logic pure, we gain a deterministic and secure execution trace. As a result, debugging shifts from guessing what might have happened to watching exactly what did happen, all without compromising user privacy.
，推荐阅读谷歌浏览器【最新下载地址】获取更多信息
唐納德·特朗普（Donald Trump，川普）總統數個月來一直警告，如果最高法院做出這樣的裁決，將是一場災難。
Tourette's film nominated for six BAFTA awards